• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Oligomerix

edit

OLIGOMERIX, Inc. is a biopharmaceutical company founded in 2006 located within the Audubon Biomedical Science and Technology Park of Columbia University. The Company is exploiting its novel research that allows rapid generation of stable amyloid oligomers as targets for drug discovery. These systems will enable target identification and validation, and drug discovery for Alzheimer’s and other neurodegenerative diseases.

Recent Milestones

edit

• 
  Oligomerix received $2.8M in Series B funding. (5/22/13)
  Posted 5/22/13 at 7:51pm via finsmes.com
• 
  Oligomerix received $2M in Series A funding. (4/23/12)
  Posted 4/23/12 at 6:26am via pehub.com
• 
  Oligomerix added Vic Micati as Chairman.
  Posted 10/20/10 at 9:54pm
• 
  Oligomerix added Jack Pasini as Director and CMO.
  Posted 10/20/10 at 9:54pm

Videos

Screenshots

edit

Sources

1. Oligomerix Inks $2M (pehub.com) [edit]
2. Oligomerix Completes $2.8M Series B Financing (finsmes.com) [edit]